Supplementary Table S7 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy

Supplementary Table S7 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy

<p>Supplementary Table S7. DEGs for 1 month Comparison of CD49d+ and CD49d-</p>

Saved in:
Bibliographic Details
Main Author: Anfal Alsadhan (15907475) (author)
Other Authors: Jonathan Chen (15907478) (author), Erika M. Gaglione (15032498) (author), Chingiz Underbayev (15907481) (author), Pamela L. Tuma (15907484) (author), Xin Tian (15907487) (author), Lita A. Freeman (15907490) (author), Sivasubramanian Baskar (15907493) (author), Pia Nierman (15907496) (author), Susan Soto (15907499) (author), Andy Itsara (15907502) (author), Inhye E. Ahn (15032501) (author), Clare Sun (14953020) (author), Elena Bibikova (15907505) (author), Tanja Nicole Hartmann (15907508) (author), Maissa Mhibik (15907511) (author), Adrian Wiestner (15907514) (author)
Published: 2025
Subjects:
Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Immuno-oncology
Cell Signaling
Cell adhesion
Protein tyrosine kinases
Drug Resistance
Hematological Cancers
Leukemias
Lymphomas
Immunology
Immunomodulation
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items